Cargando…
Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice
BACKGROUND: FTY720, an immunomodulator derived from a fungal metabolite which reduces circulating lymphocyte counts by increasing the homing of lymphocytes to the lymph nodes has recently gained interest in stroke research. The aim of this study was to evaluate the protective efficacy of FTY720 in c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068098/ https://www.ncbi.nlm.nih.gov/pubmed/21388542 http://dx.doi.org/10.1186/2040-7378-3-2 |